Effect of vitamin c supplement on anemia in peritoneal dialysis patients
Not Applicable
- Conditions
- Anemia.Scorbutic Anemia
- Registration Number
- IRCT201205089674N1
- Lead Sponsor
- Research Department- University of Medical Science -
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
1. Long-term treatment of PD (at least more than three months) 2. Hemoglobin less than 11 milligrams per liter 3. Age over 18 years - Exclusion criteria of the study: 1. Acute illness (including infectious diseases and cancer) within 3 months prior to determining the level of vitamin C 2. Any recent blood transfusion, recurrent bleeding or hemolysis 3. Supplementation with vitamin C during the 3 weeks prior to the determination of serum levels 4. Consumption of tetracycline, antacid and Cholestyramine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin. Timepoint: Before and 6 weeks after intervention. Method of measurement: Lab Method.;Vit C Level. Timepoint: Before and 6 weeks after intervention. Method of measurement: HPLC.
- Secondary Outcome Measures
Name Time Method C Reactive Protein. Timepoint: Before and 6 week after intervention. Method of measurement: Lab Method.